Literature DB >> 2108859

Structure of the gene of tum- transplantation antigen P35B: presence of a point mutation in the antigenic allele.

J P Szikora1, A Van Pel, V Brichard, M André, N Van Baren, P Henry, E De Plaen, T Boon.   

Abstract

Mutagen treatment of P815 tumour cells produces tum- variants that are rejected by syngeneic mice because they express new transplantation antigens. These 'tum-' antigens elicit a cytolytic T lymphocyte (CTL) response but no detectable antibody response. The DNA of tum- variant P35 was transfected into P815 cell line P1.HTR. Transfectants expressing tum- antigen P35B were identified on the basis of their ability to stimulate anti-P35B CTL. This was repeated with a cosmid library and a cosmid carrying the sequence encoding antigen P35B was recovered from a transfectant expressing the antigen. Gene P35B is 6 kb long and contains 11 exons. The sequence shows no homology with the previously identified tum- gene P91A nor with any gene presently recorded in the data banks. The antigenic allele of gene P35B differs from the normal allele by a point mutation located in exon 5. This mutation, which replaces a Ser by an Asn residue, was shown by site-directed mutagenesis to be responsible for the expression of the antigen. A synthetic decapeptide covering the sequence surrounding the tum- mutation rendered P815 cells sensitive to lysis by anti-P35B CTL. Surprisingly, the homologous peptide corresponding to the normal sequence of the gene had the same effect, indicating that this tum- mutation does not exert its effect by generating the aggretope or the epitope of the antigenic peptide. As observed previously with gene P91A, we found that fragments of gene P35B containing only exons 4 and 5, which were cloned in non-expression vectors, transferred efficiently the expression of the antigen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108859      PMCID: PMC551776          DOI: 10.1002/j.1460-2075.1990.tb08208.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

2.  Genetic and physical linkage of exogenous sequences in transformed cells.

Authors:  M Perucho; D Hanahan; M Wigler
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

3.  Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.

Authors:  C Uyttenhove; J Van Snick; T Boon
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

4.  Molecular cloning of a human histocompatibility antigen cDNA fragment.

Authors:  H L Ploegh; H T Orr; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

5.  Tumor cell variants obtained by mutagenesis of a Lewis lung carcinoma cell line: immune rejection by syngeneic mice.

Authors:  A Van Pel; M Georlette; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

6.  Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.

Authors:  T Boon; A Van Pel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

7.  Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.

Authors:  T Boon; O Kellermann
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

8.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

9.  Mouse histocompatibility genes: structure and organisation of a Kd gene.

Authors:  S Kvist; L Roberts; B Dobberstein
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

10.  Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.

Authors:  T Boon; J Van Snick; A Van Pel; C Uyttenhove; M Marchand
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  21 in total

1.  A new approach to the cloning of genes encoding T-cell epitopes.

Authors:  D M Scott; P J Dyson; E Simpson
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Mapping of the genes encoding tum- transplantation antigens P91A, P35B, and P198.

Authors:  P J Dyson; C de Smet; A M Knight; D Simon-Chazottes; J L Guénet; T Boon
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 3.  Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.

Authors:  P Höglund; H G Ljunggren; K Kärre; G Jay
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

4.  Do we need a pepton hypothesis?

Authors:  K F Lindahl
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 5.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Authors:  Pierre G Coulie; Benoît J Van den Eynde; Pierre van der Bruggen; Thierry Boon
Journal:  Nat Rev Cancer       Date:  2014-02       Impact factor: 60.716

6.  A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P G Coulie; F Lehmann; B Lethé; J Herman; C Lurquin; M Andrawiss; T Boon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Tum- mutation P35B generates the MHC-binding site of a new antigenic peptide.

Authors:  J P Szikora; A Van Pel; T Boon
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

8.  Efficient expression of tum- antigen P91A by transfected subgenic fragments.

Authors:  P Chomez; E De Plaen; A Van Pel; C De Smet; J P Szikora; C Lurquin; A M Lebacq-Verheyden; T Boon
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

9.  Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes.

Authors:  C Traversari; P van der Bruggen; B Van den Eynde; P Hainaut; C Lemoine; N Ohta; L Old; T Boon
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 10.  Human autologous tumor-specific T cells in malignant melanoma.

Authors:  C D Platsoucas
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.